NEUROMETRIX, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-05-02: Form 8-K; Period of report 2025-05-01; Description 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 1.02.
- 2025-03-25: Form 8-K; Period of report 2025-03-21; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2025-01-23: Form 8-K; Period of report 2025-01-16; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2024-12-30: Form 8-K; Period of report 2024-12-27; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2025-05-02 | 8-K | 2025-05-01 | 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.02 Effective as of May 1, 2025, upon the consummation of the Merger, the Company terminated the Company’s Employee Stock Purchase Plan, as amended. 2.01 The information set forth in the Introduction to this Current Report on Form 8-K (the “Introduction”) is incorporated into this Item 2.01 by reference. 3.01 The information set forth in the Introduction and under Item 2.01 is incorporated herein by reference. 3.03 The information set forth in the Introduction and under Item 2.01, Item 3.01 and Item 5.01 is incorporated herein by reference. 5.01 The information set forth in the Introduction is incorporated in this Item 5.01 by reference. 5.02 The information set forth under Item 2.01 is incorporated herein by reference. 5.03 The information set forth in the Introduction and under Item 2.01 is incorporated herein by reference. 8.01 Each CVR entitles the holder (the “Holder”), over the term of the CVR Agreement, to receive a Contingent Payment in the form of a Distribution calculated as a portion of the Proceeds, if any, during a Distribution Period (as such terms are defined in the CVR Agreement), subject to certain adjustments and deduction of certain expenses pursuant to the CVR Agreement. | form8-k.htm |
| 2025-03-25 | 8-K | 2025-03-21 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On March 21, 2025, NeuroMetrix, Inc., a Delaware corporation (“NeuroMetrix” or the “Company”), held a virtual special meeting of stockholders (the “Special Meeting”) to consider and vote on the proposals set forth in the definitive proxy statement of the Company prepared in connection with the Merger Agreement (as defined below) filed with the U.S. Securities and Exchange Commission (the “Commission”) on February 14, 2025. | tm2510331d1_8k.htm |
| 2025-01-23 | 8-K | 2025-01-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |